Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study

2020105 citationsJournal Article

Authors

Darryl P. Leong · Hamilton General Hospital

Vincent Fradet

Abstract

Two-thirds of men with prostate cancer are at high cardiovascular risk. There is a positive association between a plan to use androgen deprivation therapy and baseline cardiovascular risk factors. However, this association is explained by confounding factors.

Topics & Keywords

Prostate Cancer Treatment and Research Chemotherapy-induced cardiotoxicity and mitigation Estrogen and related hormone effects

UN Sustainable Development Goals

Gender equality

Publication Details

Published in: The Journal of Urology

Volume 203, Issue 6, pp. 1109-1116

DOI: 10.1097/ju.0000000000000714

Field-Weighted Citation Impact: 6.58